Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CUTR Stock Forecast 2026-2027
$0.01
Current Price
$165,673
Market Cap
Buy 0
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to CUTR Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
CUTR Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
0.0%
1 Year Change
0.0%
Year-to-Date Change
-99.7%
From 52W High of $2.88
+66.0%
From 52W Low of $0.00
📊 TOP ANALYST CALLS
Did CUTR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Cutera is one of their latest high-conviction picks.
Latest CUTR Stock Price Targets & Analyst Predictions
CUTR has shown a year-to-date change of 0.0% and a 1-year change of 0.0%, reflecting flat performance over the past year. Comprehensive analyst forecasts are currently unavailable for CUTR. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CUTR Analyst Ratings
0
Buy
1
Hold
0
Sell
CUTR Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.01
Latest CUTR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CUTR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 9, 2024 | Stephens & Co. | George Sellers | Overweight | Maintains | $5.00 |
| Aug 9, 2024 | Piper Sandler | Matt O'Brien | Neutral | Reiterates | $1.00 |
| Jun 25, 2024 | Stephens & Co. | George Sellers | Overweight | Reiterates | $10.00 |
| Jun 21, 2024 | Piper Sandler | Matt O'Brien | Neutral | Maintains | $3.00 |
| Mar 22, 2024 | Stephens & Co. | George Sellers | Overweight | Reiterates | $10.00 |
| Mar 22, 2024 | William Blair | Margaret Kaczor | Market Perform | Upgrade | $N/A |
| Mar 6, 2024 | Stephens & Co. | George Sellers | Overweight | Reiterates | $10.00 |
| Dec 22, 2023 | Stephens & Co. | George Sellers | Overweight | Reiterates | $10.00 |
| Nov 9, 2023 | Piper Sandler | Matt O'Brien | Neutral | Maintains | $3.00 |
| Nov 9, 2023 | Stifel | Jonathan Block | Buy | Maintains | $10.00 |
| Jul 27, 2023 | Piper Sandler | Matt O'Brien | Neutral | Upgrade | $18.00 |
| Jul 7, 2023 | Stifel | Jonathan Block | Buy | Maintains | $24.00 |
| Jun 12, 2023 | Stephens & Co. | Overweight | Reiterates | $N/A | |
| May 16, 2023 | Stephens & Co. | George Sellers | Overweight | Reiterates | $42.00 |
| May 12, 2023 | William Blair | Underperform | Downgrade | $N/A | |
| May 11, 2023 | William Blair | Margaret Kaczor | Underperform | Downgrade | $N/A |
| May 10, 2023 | Cantor Fitzgerald | Louise Chen | Neutral | Maintains | $21.00 |
| May 10, 2023 | Piper Sandler | Matt O'Brien | Underweight | Reinstates | $14.00 |
| Apr 14, 2023 | Stephens & Co. | George Sellers | Overweight | Reiterates | $46.00 |
| Apr 10, 2023 | Stephens & Co. | George Sellers | Overweight | Reiterates | $46.00 |
Cutera Inc. (CUTR) Competitors
The following stocks are similar to Cutera based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Cutera Inc. (CUTR) Financial Data
Cutera Inc. has a market capitalization of $165,673 with a P/E ratio of 0.0x. The company generates $212.37M in trailing twelve-month revenue with a 19.5% profit margin.
Revenue growth is -5.5% quarter-over-quarter, while maintaining an operating margin of -70.4% and return on equity of +94.8%.
Valuation Metrics
Market Cap
$165,673
Enterprise Value
$286.58M
P/E Ratio
0.0x
PEG Ratio
0.0x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
-5.5%
Gross Margin
+5.6%
Operating Margin
-70.4%
Net Margin
+19.5%
EPS Growth
-30.1%
Financial Health
Cash/Price Ratio
N/A
Current Ratio
2.9x
Debt/Equity
-1.7x
ROE
+94.8%
ROA
-47.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Cutera Inc. (CUTR) Business Model
About Cutera Inc.
What They Do
Develops innovative laser and energy-based aesthetic systems.
Business Model
Cutera Inc. generates revenue by developing, manufacturing, and distributing advanced laser and energy-based aesthetic systems targeted at dermatologists, plastic surgeons, and aesthetic practitioners. Its product offerings span various cosmetic and medical treatments, allowing the company to tap into multiple growing markets within healthcare, wellness, and beauty.
Additional Information
Headquartered in Brisbane, California, Cutera is recognized for its technology-driven approach, with products like Excel V, Enlighten, and truSculpt. The company is well-positioned in the expanding aesthetic market, responding to the increasing demand for non-invasive solutions.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
430
CEO
Mr. Taylor C. Harris
Country
United States
IPO Year
2004
Website
www.cutera.comCutera Inc. (CUTR) Latest News & Analysis
Latest News
Cutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure
11 months ago
Quick Summary
Cutera, Inc. has successfully completed its Chapter 11 restructuring, reducing debt by over 90% (nearly $400 million) and raising $65 million in new funding, positioning for growth.
Why It Matters
Cutera's emergence from Chapter 11 with a strengthened balance sheet and reduced debt enhances its growth potential and innovation capacity, positively influencing investor sentiment and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Cutera, Inc. (Nasdaq: CUTR) plans to voluntarily delist its common stock from Nasdaq, with a Form 25 expected to be filed around March 20, 2025.
Why It Matters
Cutera's voluntary delisting from Nasdaq signals potential issues with liquidity or financial health, likely impacting stock valuation and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success
1 year ago
Quick Summary
Cutera, Inc. is initiating a restructuring to reduce debt by nearly $400 million (over 90%) and raise $65 million, supported by lenders holding 74% of its notes.
Why It Matters
Cutera's restructuring will significantly reduce its debt, improving financial health and stability, which can enhance investor confidence and potentially increase stock value.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
The global dermatology devices market is projected to grow from $15.93 billion in 2024 to $18.38 billion in 2025, at a CAGR of 15.4%, driven by increased skin health awareness and aging population.
Why It Matters
The rapid growth of the dermatology devices market, with a projected CAGR of 15.4%, indicates strong investment opportunities in healthcare and technology sectors catering to skin health and aesthetics.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Aesthetic Medicine enhances appearance using non-invasive to minimally invasive techniques, typically administered by various specialists with local or no anesthesia.
Why It Matters
Growth in aesthetic medicine indicates rising demand for non-invasive procedures, potentially driving revenue for healthcare providers and cosmetic companies, influencing investment opportunities in the sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Cutera, Inc. (Nasdaq: CUTR) has partnered with the Adaptive Training Foundation to support individuals with physical impairments through exercise and community initiatives.
Why It Matters
Cutera's partnership with the Adaptive Training Foundation highlights its commitment to social responsibility, potentially enhancing brand reputation and customer loyalty, which can positively impact stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About CUTR Stock
What is Cutera Inc.'s (CUTR) stock forecast for 2026?
Analyst forecasts for Cutera Inc. (CUTR) are not currently available. The stock is trading at $0.01.
Is CUTR stock a good investment in 2026?
According to current analyst ratings, CUTR has 0 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.01. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CUTR stock?
Price predictions from Wall Street analysts for CUTR are not currently available. The stock is trading at $0.01.
What is Cutera Inc.'s business model?
Cutera Inc. generates revenue by developing, manufacturing, and distributing advanced laser and energy-based aesthetic systems targeted at dermatologists, plastic surgeons, and aesthetic practitioners. Its product offerings span various cosmetic and medical treatments, allowing the company to tap into multiple growing markets within healthcare, wellness, and beauty.
What is the highest forecasted price for CUTR Cutera Inc.?
Price targets from Wall Street analysts for CUTR are not currently available. The stock is trading at $0.01.
What is the lowest forecasted price for CUTR Cutera Inc.?
Price targets from Wall Street analysts for CUTR are not currently available. The stock is trading at $0.01.
What is the overall CUTR consensus from analysts for Cutera Inc.?
The overall analyst consensus for CUTR is neutral. Out of 8 Wall Street analysts, 0 rate it as Buy, 1 as Hold, and 0 as Sell.
How accurate are CUTR stock price projections?
Stock price projections, including those for Cutera Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 10, 2026 4:03 AM UTC